Advanced Oncotherapy

OverviewSuggest Edit

Advanced Oncotherapy is a specialist developer and provider of the next generation of particle therapy systems that makes radiation less toxic for patients. Our aim is to create a bright future in cancer care with our advanced LIGHT technology. Vision: To develop a more affordable proton-based radiotherapy system, using an innovative and clinically more effective technology, and saving more cancer lives. Mission: To facilitate the wider use of radiation with protons for treating all forms of radio-sensitive cancers by commercialising a novel technology, and building on the success and scientific know-how of CERN (Centre Européen pour la Recherche Nucléaire).
TypePublic
Founded1994
HQLondon, GB
Websiteavoplc.com

Latest Updates

Employees (est.) (Sept 2020)129
Revenue (FY, 2015)£84.2 K(-20%)
Share Price (Sept 2020)£0.3
Cybersecurity ratingAMore

Key People/Management at Advanced Oncotherapy

Mike Sinclair

Mike Sinclair

Executive Chairman
Nicolas Serandour

Nicolas Serandour

CEO
Ed Lee

Ed Lee

COO
Steve Myers

Steve Myers

Executive Chairman
Moataz Karmalawy

Moataz Karmalawy

Chief Commercial Officer, President US
Jonathan Farr

Jonathan Farr

Chief Clinical Officer
Show more

Advanced Oncotherapy Office Locations

Advanced Oncotherapy has offices in London, Daresbury, Syracuse, Den Haag and in 2 other locations
London, GB (HQ)
4 Tenterden St, Mayfair
Daresbury, GB
Keckwick Ln
Den Haag, NL
Kazernestraat 88D
Leiden, NL
Rijnsburgerweg 10
Meyrin, CH
Rue de Veyrot 11
Syracuse, US
120 Walton St #301
Show all (6)

Advanced Oncotherapy Financials and Metrics

Advanced Oncotherapy Revenue

Advanced Oncotherapy's revenue was reported to be £84.24 k in FY, 2015 which is a 20.8% decrease from the previous period.
GBP

Net income (FY, 2018)

(21.1m)

EBITDA (FY, 2018)

(21.4m)

EBIT (FY, 2018)

(21.8m)

Market capitalization (15-Sept-2020)

91.9m

Closing stock price (15-Sept-2020)

0.3

Cash (31-Dec-2018)

1.0m
Advanced Oncotherapy's current market capitalization is £91.9 m.
GBPFY, 2005FY, 2006FY, 2007FY, 2008FY, 2009FY, 2010FY, 2011FY, 2012FY, 2013FY, 2014FY, 2015FY, 2016FY, 2017FY, 2018

Revenue

1.7m1.8m2.1m2.9m3.4m1.4m71.0k100.0k68.9k106.4k84.2k

Revenue growth, %

54%(21%)

Cost of goods sold

73.0k84.0k163.0k416.0k455.3k1.2m713.0156.0k202.7k1.9m

Gross profit

1.7m1.7m2.0m2.4m3.0m200.0k99.3k(87.0k)(96.3k)
GBPFY, 2005FY, 2006FY, 2007FY, 2008FY, 2009FY, 2010FY, 2011FY, 2012FY, 2013FY, 2014FY, 2015FY, 2016FY, 2017FY, 2018

Cash

7.0m2.3m119.0k2.5m268.6k148.4k24.2k57.8k148.8k1.5m9.0m1.4m56.5k1.0m

Accounts Receivable

339.0k360.0k152.0k128.6k173.4k2.1m1.1m2.9k28.6k73.6k

Inventories

1.0k37.2k1.1m4.4m7.4m7.6m10.0m

Current Assets

7.3m4.6m665.0k3.0m781.1k2.7m1.5m1.5m1.4m3.2m16.7m12.5m12.5m13.7m
GBPFY, 2005FY, 2006FY, 2007FY, 2008FY, 2009FY, 2010FY, 2011FY, 2012FY, 2013FY, 2014FY, 2015FY, 2016FY, 2017FY, 2018

Net Income

(383.0k)678.0k1.5m(1.7m)(1.8m)(3.4m)(2.3m)(1.9m)(3.4m)(5.7m)(5.8m)(10.4m)(13.7m)(21.1m)

Cash From Operating Activities

1.7m1.4m(625.5k)(742.1k)(4.3m)(774.2k)(1.4m)(2.9m)(6.6m)(9.8m)(10.9m)(9.6m)(1.7m)

Cash From Financing Activities

3.4m5.6m13.9m4.9m(19.5m)(23.4m)2.4m2.5m9.2m21.1m13.1m16.8m14.7m

Net Change in Cash

4.6m4.2m4.3m(2.2m)(507.3k)(90.4k)386.8k91.2k1.3m7.5m(7.5m)(1.4m)910.7k
GBPFY, 2005

Financial Leverage

2.7 x
Show all financial metrics

Advanced Oncotherapy Cybersecurity Score

Cybersecurity ratingPremium dataset

A

97/100

SecurityScorecard logo

Advanced Oncotherapy Online and Social Media Presence

Embed Graph

Advanced Oncotherapy News and Updates

Global Proton Therapy Market 2013-2018 & 2019-2023 - Key Players are IBA Proton Therapy, Hitachi, Varian Medical Systems, Mevion Medical Systems, Advanced Oncotherapy & ProTom International

DUBLIN, Feb. 7, 2019 /PRNewswire/ -- The "Global Proton Therapy Market - Analysis By Product (Equipment, Services), By Type (Singe Room, Multi-Room), By Region, By Country (2019 Edition): Opportunities and Forecast (2013-2023)" report has been added to ResearchAndMarkets.com's offering....

Advanced Oncotherapy Frequently Asked Questions

  • When was Advanced Oncotherapy founded?

    Advanced Oncotherapy was founded in 1994.

  • Who are Advanced Oncotherapy key executives?

    Advanced Oncotherapy's key executives are Mike Sinclair, Nicolas Serandour and Ed Lee.

  • How many employees does Advanced Oncotherapy have?

    Advanced Oncotherapy has 129 employees.

  • Who are Advanced Oncotherapy competitors?

    Competitors of Advanced Oncotherapy include Addiction Campuses of America, Cmed and Fusion Antibodies.

  • Where is Advanced Oncotherapy headquarters?

    Advanced Oncotherapy headquarters is located at 4 Tenterden St, Mayfair, London.

  • Where are Advanced Oncotherapy offices?

    Advanced Oncotherapy has offices in London, Daresbury, Syracuse, Den Haag and in 2 other locations.

  • How many offices does Advanced Oncotherapy have?

    Advanced Oncotherapy has 6 offices.